Evidence map›Paper›PMID 32936304›Full record

Observational studyBioscience reports2020

Identification and verification of three key genes associated with survival and prognosis of COAD patients via integrated bioinformatics analysis.

Yong Liu, Chao Li, Lijin Dong, Xuewei Chen, Rong Fan

Abstract readObservational Study
In one paragraph

Observational study in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yong Liu *Department of General Surgery, Tianjin Xiqing Hospital, Tianjin 300380, P.R. China.
Chao Li *Department of Operational Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin 300050, P.R. China.
Lijin DongEditorial Department of Education and Research Security Centre, Logistic University of Chinese People's Armed Police Force, Tianjin 300309, P.R. China.
Xuewei ChenDepartment of Operational Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin 300050, P.R. China.
Rong FanDepartment of Operational Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin 300050, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is the third most lethal malignancy in the world, wherein colon adenocarcinoma (COAD) is the most prevalent type of CRC. Exploring biomarkers is important for the diagnosis, treatment, and prevention of COAD.

methodsWe used GEO2R and Venn online software for differential gene screening analysis. Hub genes were screened via Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and Cytoscape, following Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Finally, survival analysis and RNA expression validation were performed via UALCAN online software and real-time PCR. Immunohistochemistry (IHC) was performed to verify the protein expression level of hub genes from tissues of COAD patients.

resultsIn the present study, we screened 323 common differentially expressed genes (DEGs) from four GSE datasets. Furthermore, four hub genes were selected for survival correlation analysis and expression level verification, three of which were shown to be statistically significant.

conclusionOur study suggests that Serpin Family E Member 1 (SERPINE1), secreted phosphoprotein 1 (SPP1) and tissue inhibitor of metalloproteinase 1 (TIMP1) may be biomarkers closely related to the prognosis of CRC patients.

Indexed as

AdenocarcinomaBiomarkers, TumorCell Line, TumorColectomyColonColonic NeoplasmsComputational BiologyDatasets as TopicGene Expression ProfilingHumansOsteopontinPlasminogen Activator Inhibitor 1PrognosisProtein Interaction MappingProtein Interaction MapsSurvival AnalysisBiomarkers, TumorOsteopontinPlasminogen Activator Inhibitor 1SERPINE1 protein, humanSPP1 protein, humanTIMP1 protein, humanTissue Inhibitor of Metalloproteinase-1bioinformatics analysisbiomarkersColon adenocarcinomacolorectal cancer

Identifiers

PMID32936304
PMCPMC7522359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.